Jonathan Friedberg
@drjfriedberg
Lymphoma expert. Director of @WilmotCancer Rochester NY. Editor-in-Chief, Journal of Clinical Oncology @asco_pubs. Tweets and opinions are my own.
ID: 2886201454
http://www.urmc.rochester.edu/people/20880804-jonathan-w-friedberg 20-11-2014 21:50:17
2,2K Tweet
5,5K Takipçi
410 Takip Edilen
Spikes left a heartfelt message for our patients when he visited last week. ❤️ Want to see him in person? Join us for Wilmot Cancer Institute Survivors Night with the Rochester Red Wings on July 25! Details: urmc.info/25v
Thoughtful Journal of Clinical Oncology editorial on Treatment of Hodgkin Lymphoma in Older Patients: "N-AVD should become the new standard...BrECADD is an alternative in very fit older adults where response-adapted treatment would be appropriate." ascopubs.org/doi/full/10.12…
Thanks to #ROC and Rochester Red Wings for a great night celebrating cancer survivors. Wilmot Cancer Institute
Honoured to help celebrate cancer survivorship at the Wilmot Cancer Institute Survivorship night at the Rochester Red Wings baseball game! The ASCO Post Wilmot Cancer Institute Pluta Cancer Center Foundation International Cardio-Oncology Society
A Cure, a Cure, My Kingdom for a Cure: patients with refractory myeloma can achieve long-term remissions following CAR-T therapy, earlier use may cure more. Thoughtful Journal of Clinical Oncology commentary Sagar Lonial MD ascopubs.org/doi/full/10.12…
Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: These results show the importance of continued screening for late effects in adulthood; further studies of older survivors needed as treatments continue to evolve. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…
Fantastic Wilmot Cancer Institute research retreat today; first one as National Cancer Institute designated center. Amazing collaborative opportunities identified. #ROC UR Medicine University of Rochester
Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…
Microbiome Modulation for the Treatment of Solid Neoplasms: fascinating area of rapid progress. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…
Record year for Presley and Haley's hot dog stand for Wilmot Cancer Institute Thanks to all in Nunda NY for this outstanding support.
edelmancrf.com Thank You to Dr. Karen Mustian, Dr Charlie Kaman, Dr Tracie McGinnity, Community Outreach and Barb Balcean from WCI. You’re always there to support us and educate the community. Your support means a lot! Another successful fundraiser season for research. Thank you!❤️
Excited to introduce "Bridging the Gap": a new Journal of Clinical Oncology article type which features a practical case presentation integrating the findings of an Original Report into the management approach, and highlights considerations of implementation into practice. ascopubs.org/doi/10.1200/JC…
BMT CTN 1702: Refining the donor search algorithm has the potential to increase access to transplant for patients whose likelihood of identifying a well matched donor is low. Journal of Clinical Oncology ascopubs.org/doi/full/10.12…
PROs vs clinician-reported adverse events in the POLARIX study: we are insufficiently capturing patient experience with conventional toxicity assessments. Great collaboration with Dr. Carrie Thompson Mayo Clinic Wilmot Cancer Institute ashpublications.org/blood/article/…
Gorgeous #ROC morning for Wilmot Cancer Institute Warrior Weekend. Your support makes us work harder in the fight against cancer.
So inspired by the broad participation and support for Wilmot Cancer Institute on this beautiful day. Thanks to all!!
